Arcosa (ACA) EBITDA (2017 - 2026)

Arcosa has reported EBITDA for 10 years, with the latest figure at $47.1 million in Q1 2026.

• Quarterly EBITDA rose 14.88% year-over-year to $47.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $333.2 million (up 79.91% YoY) and the FY2025 annual result came in at $341.9 million, up 73.03% from the prior year.
• EBITDA retreated to $47.1 million in Q1 2026 per ACA's latest filing, from $79.0 million in the prior quarter.
• Over five years, EBITDA peaked at $208.1 million in Q4 2022 and troughed at $33.8 million in Q3 2024.
• A 5-year average of $66.9 million and a median of $51.0 million in 2023 frame the typical range for EBITDA.
• The sharpest annual moves came in 2022 and 2023: EBITDA soared 1233.97% in 2022, then sank 79.43% in 2023.
• Over 5 years, EBITDA stood at $208.1 million in 2022, then tumbled by 79.43% to $42.8 million in 2023, then grew by 0.93% to $43.2 million in 2024, then soared by 82.87% to $79.0 million in 2025, then slumped by 40.38% to $47.1 million in 2026.
• According to Business Quant data, EBITDA over the past three periods registered $47.1 million, $79.0 million, and $112.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.